Patent · US Active

Azaindoles useful as inhibitors of Janus kinases

US9120790B2 · kind B2 · utility

14Cited by
12References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 24, 2014
Grant dateSep 1, 2015
Priority date
Expiry dateJul 24, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y207/10002
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds useful as inhibitors of protein kinases, particularly of JAK family kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.